BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15122070)

  • 21. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores.
    Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA
    J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers.
    Gregson SJ; Howard PW; Gullick DR; Hamaguchi A; Corcoran KE; Brooks NA; Hartley JA; Jenkins TC; Patel S; Guille MJ; Thurston DE
    J Med Chem; 2004 Feb; 47(5):1161-74. PubMed ID: 14971896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of pyrrolobenzodiazepine dimers and duplex DNA from methicillin-resistant Staphylococcus aureus.
    Hadjivassileva T; Stapleton PD; Thurston DE; Taylor PW
    Int J Antimicrob Agents; 2007 Jun; 29(6):672-8. PubMed ID: 17350809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120.
    Walton MI; Goddard P; Kelland LR; Thurston DE; Harrap KR
    Cancer Chemother Pharmacol; 1996; 38(5):431-8. PubMed ID: 8765436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.
    Janjigian YY; Lee W; Kris MG; Miller VA; Krug LM; Azzoli CG; Senturk E; Calcutt MW; Rizvi NA
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):833-8. PubMed ID: 19672598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136.
    Aird RE; Thomson M; Macpherson JS; Thurston DE; Jodrell DI; Guichard SM
    Pharmacogenomics J; 2008 Aug; 8(4):289-96. PubMed ID: 17563765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I pharmacokinetic and pharmacodynamic study of SJG-136, a novel DNA sequence selective minor groove cross-linking agent, in advanced solid tumors.
    Puzanov I; Lee W; Chen AP; Calcutt MW; Hachey DL; Vermeulen WL; Spanswick VJ; Liao CY; Hartley JA; Berlin JD; Rothenberg ML
    Clin Cancer Res; 2011 Jun; 17(11):3794-802. PubMed ID: 21346148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors.
    Hochhauser D; Meyer T; Spanswick VJ; Wu J; Clingen PH; Loadman P; Cobb M; Gumbrell L; Begent RH; Hartley JA; Jodrell D
    Clin Cancer Res; 2009 Mar; 15(6):2140-7. PubMed ID: 19276288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling.
    Arnould S; Spanswick VJ; Macpherson JS; Hartley JA; Thurston DE; Jodrell DI; Guichard SM
    Mol Cancer Ther; 2006 Jun; 5(6):1602-9. PubMed ID: 16818520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity.
    Kamal A; Ramesh G; Laxman N; Ramulu P; Srinivas O; Neelima K; Kondapi AK; Sreenu VB; Nagarajaram HA
    J Med Chem; 2002 Oct; 45(21):4679-88. PubMed ID: 12361394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An asymmetric C8/C8'-tripyrrole-linked sequence-selective pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimer DNA interstrand cross-linking agent spanning 11 DNA base pairs.
    Tiberghien AC; Evans DA; Kiakos K; Martin CR; Hartley JA; Thurston DE; Howard PW
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2073-7. PubMed ID: 18272367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells.
    Pepper C; Lowe H; Fegan C; Thurieau C; Thurston DE; Hartley JA; Delavault P
    Br J Cancer; 2007 Jul; 97(2):253-9. PubMed ID: 17579621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear magnetic resonance solution structures of inter- and intrastrand adducts of DNA cross-linker SJG-136.
    Hopton SR; Thompson AS
    Biochemistry; 2011 May; 50(21):4720-32. PubMed ID: 21488658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA interstrand cross-linking and in vivo antitumor activity of the extended pyrrolo[2,1-c][1,4]benzodiazepine dimer SG2057.
    Hartley JA; Hamaguchi A; Suggitt M; Gregson SJ; Thurston DE; Howard PW
    Invest New Drugs; 2012 Jun; 30(3):950-8. PubMed ID: 21384134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of benzo[c,d]indolone-pyrrolobenzodiazepine conjugates as potential anticancer agents.
    Kamal A; Ramakrishna G; Lakshma Nayak V; Raju P; Subba Rao AV; Viswanath A; Vishnuvardhan MV; Ramakrishna S; Srinivas G
    Bioorg Med Chem; 2012 Jan; 20(2):789-800. PubMed ID: 22209733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence-selective recognition of duplex DNA through covalent interstrand cross-linking: kinetic and molecular modeling studies with pyrrolobenzodiazepine dimers.
    Smellie M; Bose DS; Thompson AS; Jenkins TC; Hartley JA; Thurston DE
    Biochemistry; 2003 Jul; 42(27):8232-9. PubMed ID: 12846572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).
    Mantaj J; Jackson PJ; Rahman KM; Thurston DE
    Angew Chem Int Ed Engl; 2017 Jan; 56(2):462-488. PubMed ID: 27862776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of fluorinated analogues of SJG-136 and their DNA-binding potential.
    Kamal A; Reddy PS; Reddy DR; Laxman E; Murthy YL
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5699-702. PubMed ID: 15482951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs.
    Cipolla L; Araújo AC; Airoldi C; Bini D
    Anticancer Agents Med Chem; 2009 Jan; 9(1):1-31. PubMed ID: 19149479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119).
    Burger AM; Loadman PM; Thurston DE; Schultz R; Fiebig HH; Bibby MC
    J Chemother; 2007 Feb; 19(1):66-78. PubMed ID: 17309854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.